Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
0 hedge funds and large institutions have $0 invested in Spectrum Pharmaceuticals Inc in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 77 closing their positions.
100% less funds holding
Funds holding: 78 → 0 (-78)
100% less capital invested
Capital invested by funds: $56.5M → $0 (-$56.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 77
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$19.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.24M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.69M |
| 4 |
BlackRock
New York
|
-$3.34M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.79M |
SPPI Hedge Fund Activity: Q3 2023 in Review
0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2023, worth a combined $0 — down 100% from $56.5M a quarter earlier.
Sellers outnumbered buyers: 77 funds closed out of SPPI and 0 opened new positions — a net loss of 77 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Armistice Capital, exiting entirely with an estimated $19.2M sold.
- 0 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2023, down from 78 in Q2 2023.
- Funds reported $0 of Spectrum Pharmaceuticals Inc stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2023 and 77 closed out, a net change of -77 holders.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2023 was Armistice Capital, an estimated $19.2M sold.
Based on aggregated 13F filings for Q3 2023.